Carlsmed Inc Earnings: Beat on EPS and Revenue

Carlsmed Inc (CARL) reported better-than-expected quarterly results on May 5, 2026, beating analyst estimates on both earnings per share and revenue. The medical device company posted an EPS loss of $0.32 versus the expected loss of $0.40, representing a 19.96% positive surprise.

The company’s EPS of -$0.32 came in $0.08 better than the consensus estimate of -$0.40, marking a significant improvement over analyst projections. This 19.96% earnings surprise demonstrates stronger operational performance than Wall Street anticipated.

Revenue for the quarter reached $16.12 million, surpassing analyst estimates of $15.28 million by $836,320. The 5.47% revenue surprise indicates growing demand for Carlsmed’s products, with actual sales exceeding expectations by approximately $0.84 million.

The dual beat on both EPS and revenue metrics suggests improved financial execution across Carlsmed’s operations. The company’s ability to exceed the -$0.40 EPS estimate by delivering -$0.32 reflects better cost management, while the $16.12 million revenue figure beating the $15.28 million estimate shows solid top-line growth momentum.

This article is for informational purposes only and does not constitute investment advice. Past performance does not guarantee future results.